(Q40804420)

English

Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.

scientific article published on October 1986

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

title

Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

author name string

Abdi EA

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

McPherson TA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

Tan YH

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

publication date

1 October 1986

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

published in

Journal of biological response modifiers

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

page(s)

423-428

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 October 2019

Identifiers

PubMed publication ID

3772395

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3772395

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3772395%20AND%20SRC:MED&resulttype=core&format=json

(Q40804420)

Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)